Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
KOBE BUSSAN, Nov-Jan (1Q) Ordinary Profit Decreases by 43%
3038 KOBE BUSSAN CO.,LTD. 【J-GAAP】
Earnings ReportKOBE BUSSAN CO.,LTD. <3038> [TSE Prime] announced its financial results after the market closed on March 13th (15:30). The consolidated ordinary profit for the first quarter of the fiscal year ending October 2026 (November 2025 to January 2026) dropped 43.5% from the same period last year to 8.76 billion yen. Progress toward the full-year plan of 43.7 billion yen was 20.1%, almost the same as the five-year average of 22.5%.
In the most recent three-month period, from November to January (1Q), the operating profit margin improved from 6.9% in the same period last year to 7.7%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Nov - Jan, 2023 | 120,904 | 8,531 | 8,063 | 5,524 | 25.0 | 44.7 | Mar 14, 2024 | J-GAAP |
| Nov - Jan, 2024 | 132,425 | 9,154 | 15,510 | 10,588 | 47.9 | 74.1 | Mar 14, 2025 | J-GAAP |
| Nov - Jan, 2025 | 141,598 | 10,945 | 8,764 | 5,910 | 26.7 | ー | Mar 13, 2026 | J-GAAP |
| YoY | +6.9% | +19.6% | -43.5% | -44.2% | -44.3% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Nov - Apr, 2024 | 272,306 | 19,086 | 20,929 | 14,267 | 64.5 | 0 | Jun 12, 2025 | J-GAAP |
| Nov - Apr, 2025 Guidance | ー | ー | ー | ー | - | 0 | Dec 12, 2025 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct, 2024 | 507,883 | 34,350 | 31,576 | 21,443 | 97.1 | 23 | Dec 13, 2024 | J-GAAP |
| Oct, 2025 | 551,701 | 39,878 | 48,081 | 31,878 | 144.0 | 30 | Dec 12, 2025 | J-GAAP |
| Oct, 2026 Guidance | 566,500 | 43,000 | 43,700 | 29,500 | 133.0 | 32 | Dec 12, 2025 | J-GAAP |
| YoY | +2.7% | +7.8% | -9.1% | -7.5% | -7.6% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Nov - Jan, 2024 | 132,425 | 9,154 | 15,510 | 10,588 | 47.9 | 6.9 | Mar 14, 2025 | J-GAAP |
| Feb - Apr, 2025 | 139,881 | 9,932 | 5,419 | 3,679 | 16.6 | 7.1 | Jun 12, 2025 | J-GAAP |
| May - Jul, 2025 | 139,247 | 11,253 | 17,320 | 11,932 | 53.9 | 8.1 | Sep 11, 2025 | J-GAAP |
| Aug - Oct, 2025 | 140,148 | 9,539 | 9,832 | 5,679 | 25.7 | 6.8 | Dec 12, 2025 | J-GAAP |
| Nov - Jan, 2025 | 141,598 | 10,945 | 8,764 | 5,910 | 26.7 | 7.7 | Mar 13, 2026 | J-GAAP |
| YoY | +6.9% | +19.6% | -43.5% | -44.2% | -44.3% |
Related Articles
BrightPath Biotherapeutics, Net Income Forecast for the Fiscal Year Loss Widened in Downward Revision
Kura Sushi, Nov-Jan (1Q) Ordinary Profit Increases by 12%
Tri Chemical, 11% Decrease in Ordinary Profit for The Current Fiscal Year
OSG, 2.3 times Increase in Ordinary Profit for The Current Fiscal Year
TOWA BANK, Net Income Forecast for the Fiscal Year Revised Downward to a Loss
Morozoff Limited, 5% Increase in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 2 Yen, Plan to Continue the 16 Yen Policy This Fiscal Year as Well
SAKURASAKU PLUS, First Half Ordinary Profit Increases by 3.1 times, Nov-Jan Ordinary Profit Increases by 43%
Kin-Ei Corp, Ordinary Profit Forecast for Last Fiscal Year Revised Upward to an Unexpected 7% Increase
NIFTY Lifestyle, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 10%, Dividend Revised Upward by 3 Yen
CARE TWENTYONE, Nov-Jan (1Q) Ordinary Profit Turns to Profit, Exceeds First Half Plan